Find similar content

Source channel @githubtrending · Post #15201 · Oct 6

#python#security#security_tools#vulnerability#vulnerability_databases#vulnerability_management#vulnerability_scanners OSV is a free, open-source database and toolset that helps you find and manage security vulnerabilities in open source software you use. It collects vulnerability data from many sources, including official advisories and automated scans, and presents it in a clear, machine-readable format. You can use the OSV scanner tool to automatically check your software dependencies for known security issues, helping you fix them quickly. This improves your software’s security by focusing on real risks and making vulnerability management easier and more efficient. OSV also offers APIs and integrates with other tools for automation and alerts. https://github.com/google/osv.dev

Hashtags

#python #security #security_tools #vulnerability #vulnerability_databases #vulnerability_management #vulnerability_scanners

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment